Your browser doesn't support javascript.
loading
The Prevalence of glucose dysregulations (GDs) in patients with ß-thalassemias in different countries: A preliminary ICET-A survey.
De Sanctis, Vincenzo; Soliman, Ashraf; Tzoulis, Ploutarchos; Daar, Shahina; Kattamis, Antonis; Delaporta, Polyxeni; Yassin, Mohamed A; Karimi, Mehran; Canatan, Duran; Al Jaouni, Soad; Galati, Maria Concetta; Raiola, Giuseppe; Messina, Giuseppe; Campisi, Saveria; Saki, Forough; Kottahachchi, Dulani; Kaleva, Valeria; Petrova, Kristina; Banchev, Atanas; Kattamis, Christos.
Afiliação
  • De Sanctis V; Quisisana Hospital, Ferrara. vdesanctis@libero.it.
  • Soliman A; Department of Pediatrics, Division of Endocrinology, Hamad General Hospital, Doha, Qatar and Department of Pediatrics, Division of Endocrinology, Alexandria University Children's Hospital, Alexandria, Egypt. atsoliman56@gmail.com.
  • Tzoulis P; Department of Diabetes and Endocrinology, Whittington Hospital, University College London, London, UK. vdesanctis@libero.it.
  • Daar S; Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Sultanate of Oman. vdesanctis@libero.it.
  • Kattamis A; Thalassemia Unit, Division of Pediatric Hematology-Oncology, First Department of Pediatrics, University of Athens, "Agia Sofia" Children's Hospital, Athens, Greece. vdesanctis@libero.it.
  • Delaporta P; Thalassemia Unit, Division of Pediatric Hematology-Oncology, First Department of Pediatrics, University of Athens, "Agia Sofia" Children's Hospital, Athens, Greece. vdesanctis@libero.it.
  • Yassin MA; National Center for Cancer Care and Research, Medical Oncology Hematology Section HMC, Doha, Qatar. vdesanctis@libero.it.
  • Karimi M; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. vdesanctis@libero.it.
  • Canatan D; Medical Director of Antalya Genetic Diseases Center, Antalya, Turkey. vdesanctis@libero.it.
  • Al Jaouni S; Head Division of Pediatric Hematology Oncology, Department of Hematology Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. vdesanctis@libero.it.
  • Galati MC; Department of Pediatric Haematoncology, Thalassaemia and Prenatal Diagnosis Regional Center, Pugliese-Ciaccio Hospital, Catanzaro, Italy. vdesanctis@libero.it.
  • Raiola G; Department of Paediatrics, Pugliese-Ciaccio Hospital,Catanzaro, Italy. vdesanctis@libero.it.
  • Messina G; UOSD Microcitemie, Grande Ospedale Metropolitano "Bianchi- Melacrino- Morelli", Reggio Calabria, Italy. vdesanctis@libero.it.
  • Campisi S; UOSD Thalassemia, Umberto I° Hospital, Siracusa, Italy. vdesanctis@libero.it.
  • Saki F; Shiraz Endocrinology and Metabolism Research Center, Shiraz, Iran. vdesanctis@libero.it.
  • Kottahachchi D; Thalassaemia Care Unit, Colombo North Teaching Hospital, Sri Lanka. vdesanctis@libero.it.
  • Kaleva V; Varna Expert Center for Coagulopathies and Rare Anemias, Sofia, Bulgaria. vdesanctis@libero.it.
  • Petrova K; Varna Expert Center for Coagulopathies and Rare Anemias, Sofia, Bulgaria. vdesanctis@libero.it.
  • Banchev A; Pediatric Hematology-Oncology, University Hospital "Tzaritza Giovanna - ISUL", Sofia, Bulgaria. vdesanctis@libero.it.
  • Kattamis C; First Department of Paediatrics, National Kapodistrian University of Athens, Greece. vdesanctis@libero.it.
Acta Biomed ; 92(3): e2021240, 2021 07 01.
Article em En | MEDLINE | ID: mdl-34212897

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talassemia beta Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talassemia beta Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article